The oral manifestations of CD.
Takeda selects former CRISPR Therapeutics CMO to lead oncology unit; Emile Nuwaysir out at Ensoma
→ A spokesperson for Takeda tells Peer Review that PK Morrow succeeded Chris Arendt as head of oncology on Jan. 29. A few weeks ago